In Silico Solutions, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
In Silico Solutions, LLC - overview
Established
2007
Location
Fairfax, VA, US
Primary Industry
Software
About
Based in Virginia, US, and founded in 2007 by Dr. Michael Ryan, In Silico Solutions, LLC is a bioinformatics services company that develops data analysis and software tools for genome-wide research projects. In June 2021, Kiromic BioPharma, Inc. , a portfolio company, acquired In Silico Solutions, LLC.
In Silico Solutions provides bioinformatics analytical software tools that help in biological data extraction and insights from different genomic data. The company also provides bioinformatics applications to perform complex data analysis along with offering users intuitive, visual interfaces that make exploring the data easier. Some of the software tools developed by the company include SpliceCenter, LSSNP PDB, CRAVAT, SpliceSeq, MuPIT, and more. In Silicon Solutions also design and develops websites that disseminate scientific content and deliver huge datasets that are getting bigger.
In addition, the firm performs contract research and collaborates on grand-funded research with commercial organizations, government agencies, and academicians.
Current Investors
Kiromic BioPharma, Inc.
Primary Industry
Software
Sub Industries
Bioinformatics, Web Development, Analytics & Performance Software
Website
www.insilico.us.com
Verticals
HealthTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.